BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322 [PMID: 35068871 DOI: 10.3748/wjg.v27.i48.8302]
URL: https://www.wjgnet.com/2307-8960/full/v27/i48/8302.htm
Number Citing Articles
1
Yuan Fang, XiaoLi Zhang, HanFei Huang, Zhong Zeng. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little thingsJournal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04238-9
2
Ping Zhou, Wei Yao, Lijuan Liu, Qiujin Yan, Xiaobei Chen, Xiaocui Wei, Shuang Ding, Zhao Lv, Fan Zhu. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinomaCellular Oncology 2024;  doi: 10.1007/s13402-024-00955-5
3
Hongyi Liu, Ruiyue Dang, Wei Zhang, Jidong Hong, Xuejun Li. SNARE proteins: Core engines of membrane fusion in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; : 189148 doi: 10.1016/j.bbcan.2024.189148
4
Jin Wang, Yali Yang, Jingyi Lu, Xia Wang. The role of exosomes in therapeutic resistance of hepatocellular carcinomaHepatoma Research 2023;  doi: 10.20517/2394-5079.2023.85
5
Veronica Zelli, Chiara Compagnoni, Roberta Capelli, Alessandra Corrente, Mauro Di Vito Nolfi, Francesca Zazzeroni, Edoardo Alesse, Alessandra Tessitore. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.940056
6
Adane Adugna. Histomolecular characterisation of hepatitis B virus induced liver cancerReviews in Medical Virology 2023; 33(6) doi: 10.1002/rmv.2485
7
Yingying Ding, Yong Zhang, Xuehong Liu. Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxiaFrontiers in Molecular Neuroscience 2022; 15 doi: 10.3389/fnmol.2022.1043947
8
Ziyang Ye, Wenjie Chen, Genpeng Li, Jing Huang, Jianyong Lei. Tissue-derived extracellular vesicles in cancer progression: mechanisms, roles, and potential applicationsCancer and Metastasis Reviews 2024; 43(2): 575 doi: 10.1007/s10555-023-10147-6
9
Łukasz Ważny, Theresa L. Whiteside, Monika Pietrowska. Oncoviral Infections and Small Extracellular VesiclesViruses 2024; 16(8): 1291 doi: 10.3390/v16081291
10
Ming-He Zhang, Yu-Feng Yuan, Li-Juan Liu, Yu-Xin Wei, Wan-Yue Yin, Lan-Zhuo-Yin Zheng, Ying-Ying Tang, Zhao Lv, Fan Zhu. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(31): 4706-4735 doi: 10.3748/wjg.v29.i31.4706
11
Tian Zhang, Lingling Guan, Xiaomeng Xie, Lixing Guo, Dongjing Ni. Microrna-135A-5P promotes proliferation and metastasis of hepatocelluar carcinoma cells via upregulation of FOXO1Brazilian Journal of Pharmaceutical Sciences 2024; 60 doi: 10.1590/s2175-97902024e23870
12
Ziyu Liu, Yanan Li, Yufeng Wang, Xinquan Bai, Ying Zhang. Exosomes in HBV infectionClinica Chimica Acta 2023; 538: 65 doi: 10.1016/j.cca.2022.11.012
13
Lijuan Liu, Zhao Lv, Miao Wang, Dongyan Zhang, Dongying Liu, Fan Zhu. HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via SRSF2-Mediated Abnormal PCLAF SplicingInternational Journal of Molecular Sciences 2023; 24(4): 3263 doi: 10.3390/ijms24043263
14
聪聪 谭. Advances in the Diagnosis and Treatment of Exosomal miRNA in Liver CancerAdvances in Clinical Medicine 2024; 14(05): 2093 doi: 10.12677/acm.2024.1451655
15
Hanjia Zhang, Xuanyi Liu, Jiuming Shi, Xuan Su, Jiayuan Xie, Qingfeng Meng, Hao Dong. Research progress on the mechanism of exosome-mediated virus infectionFrontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1418168
16
Li-Juan Liu, Zhao Lv, Xing Xue, Zhong-Yuan Xing, Fan Zhu. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting MitophagyCancers 2022; 14(23): 5781 doi: 10.3390/cancers14235781
17
Man Yao, Shufang Liang, Binbin Cheng. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicineFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1110922
18
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al-Hetty, Pushpamala Ramaiah, Alaa Hameed Fazaa, Abduladheem Turki Jalil, Fahad Alsaikhan, Jitendra Gupta, Andrés Alexis Ramírez-Coronel, Nahla A. Tayyib, Hu Peng. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpointEnvironmental Research 2023; 227: 115683 doi: 10.1016/j.envres.2023.115683
19
Xiaojing Wu, Junqi Niu, Ying Shi. Exosomes target HBV-host interactions to remodel the hepatic immune microenvironmentJournal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02544-y
20
Zhao Lv, Lijuan Liu, Jian You, Ping Zhou, Yaru Su, Kexin Zhao, Jiahang Zhang, Fan Zhu. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429‐dependent m6A modification of CCR9Journal of Medical Virology 2024; 96(9) doi: 10.1002/jmv.29894